BCAL Diagnostics (ASX:BDX) Total Stockholders Equity : A$6.07 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Total Stockholders Equity?

BCAL Diagnostics's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$6.07 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. BCAL Diagnostics's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. BCAL Diagnostics's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.25.

BCAL Diagnostics Total Stockholders Equity Historical Data

The historical data trend for BCAL Diagnostics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Total Stockholders Equity Chart

BCAL Diagnostics Annual Data

Trend

Jun22

Jun23

Total Stockholders Equity

9.64

5.21

BCAL Diagnostics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial			11.68	9.64	7.53	5.21	6.07

BCAL Diagnostics (ASX:BDX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

BCAL Diagnostics's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(6.067	-	0)	/	251.639
	=	0.02

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

BCAL Diagnostics's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.364	+	1.139)	/	6.067
	=	0.25

BCAL Diagnostics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BCAL Diagnostics (ASX:BDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230

Website

https://www.bcaldiagnostics.com

BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.